Angiografía-OCT para diagnóstico y respuesta al tratamiento de la neovascularización subretiniana secundaria a telangiectasia macular idiopática tipo 2

  1. H.E. Tapia Quijada 1
  2. C. Mantolan Sarmiento 1
  3. S. Gómez Perera 1
  4. M. Serrano García 12
  5. N. Betancor Caro 12
  6. B. Haro Álvarez 3
  1. 1 Hospital Universitario de Canarias
    info

    Hospital Universitario de Canarias

    San Cristóbal de La Laguna, España

    ROR https://ror.org/05qndj312

  2. 2 Centro de Enfermedades Oculares Serrano, Tenerife, España
  3. 3 Instituto de Oftalmología Aplicada de Valladolid
    info

    Instituto de Oftalmología Aplicada de Valladolid

    Valladolid, España

Show affiliations +
Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2022

Volume: 97

Issue: 4

Pages: 224-229

Type: Article

DOI: 10.1016/J.OFTAL.2020.11.020 DIALNET GOOGLE SCHOLAR

More publications in: Archivos de la Sociedad Española de Oftalmologia

Abstract

Idiopathic macular telangiectasia type 2 (MacTel 2) is a slow and progressive bilateral condition that affects middle-aged and elderly individuals. Vision loss is generally mild and occurs over the course of many years. The development of sub-retinal neovascularisation (SRNV) can occur late in the disease process, and lead to more dramatic vision loss. A report is presented of 2 cases of MacTel 2 in which optical coherence tomography angiography (OCTA) was essential for the diagnosis of secondary SRNV. The commercially available OCTA Cirrus AngioPlex 5000 platform (Zeiss, Jena, Germany) was used. Subretinal neovascularization was detectable in both cases in OCTA at the level of the deep capillary plexus and the avascular layer. OCTA also allowed us to monitor disease progression and monitor response to anti-VEGF therapy.

Data source: Dialnet